Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma

Mary‐Ann El Sharouni; Karina Aivazian; Arjen J. Witkamp; V. Sigurdsson; Carla H. van Gils; Richard A Scolyer; John F. Thompson; P. J. van Diest; Serigne Lo

doi:10.1001/jamadermatol.2020.5032

Related publications

Letter2002

Clinical and histologic features of level 2 cutaneous malignant melanoma associated with metastasis

Helen M. Shaw, William H. McCarthy, Richard A Scolyer

Article2011

Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma

Rajmohan Murali, Lauren E. Haydu, Michael J. Quinn, Robyn P.M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, John F. Thompson, Richard A Scolyer

Article2024

Risk of Death Due to Melanoma and Other Causes in Patients With Thin Cutaneous Melanomas

Serigne Lo, Gabrielle Williams, Anne Ε. Cust, David W. Ollila, Alexander H. R. Varey, Sydney Ch’ng, Richard A Scolyer, John F. Thompson

Article2009

Prognostic impact of cancer-testis antigen expression in primary cutaneous melanoma

Jonathan Cebon, Šárka Svobodová, Jeffrey L. Browning, Ian D. Davis, Richard A Scolyer, Ramachandran Murali, John F. Thompson, Sumitra Deb, A. Azad, Duncan MacGregor

Article2023

Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study

Iman Osman, M. Berwick, InterMEL, Li Luo, Judy R. Rees, Sheri L. Holmen, Jennifer S. Ko, Kathleen Conway, Pauline Funchain, M.S. Ernstoff, Adam Z. Reynolds, Nancy E. Thomas, Marcus Bosenberg, Venkatraman Seshan, Arshi Arora, Tawny W. Boyce, Peter Ngo, Matthew Schwartz, C.L. Thompson, I. Gorlov, Shenying Fang, P.F. Kuan, Graham J. Mann, Irene Orlow, Eva Hernando, ,